BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 14691340)

  • 1. Relationships between serum IGF-1, IGFBP-2, interleukin-1beta and interleukin-6 in inflammatory bowel disease.
    Street ME; de'Angelis G; Camacho-Hübner C; Giovannelli G; Ziveri MA; Bacchini PL; Bernasconi S; Sansebastiano G; Savage MO
    Horm Res; 2004; 61(4):159-64. PubMed ID: 14691340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The insulin-like growth factor system and markers of inflammation in adult patients with inflammatory bowel disease.
    Eivindson M; Nielsen JN; Grønbaek H; Flyvbjerg A; Hey H
    Horm Res; 2005; 64(1):9-15. PubMed ID: 16088202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced serum insulin-like growth factor-1 (IGF-1) and IGF-binding protein-3 levels in adults with inflammatory bowel disease.
    Katsanos KH; Tsatsoulis A; Christodoulou D; Challa A; Katsaraki A; Tsianos EV
    Growth Horm IGF Res; 2001 Dec; 11(6):364-7. PubMed ID: 11914023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevation of serum interleukin-6 but not serum-soluble interleukin-2 receptor in children with Crohn's disease.
    Bross DA; Leichtner AM; Zurakowski D; Law T; Bousvaros A
    J Pediatr Gastroenterol Nutr; 1996 Aug; 23(2):164-71. PubMed ID: 8856584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammation is a modulator of the insulin-like growth factor (IGF)/IGF-binding protein system inducing reduced bioactivity of IGFs in cystic fibrosis.
    Street ME; Ziveri MA; Spaggiari C; Viani I; Volta C; Grzincich GL; Virdis R; Bernasconi S
    Eur J Endocrinol; 2006 Jan; 154(1):47-52. PubMed ID: 16381990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The insulin-like growth factor (IGF)-system in active ulcerative colitis and Crohn's disease: relations to disease activity and corticosteroid treatment.
    Eivindson M; Grønbaek H; Flyvbjerg A; Frystyk J; Zimmermann-Nielsen E; Dahlerup JF
    Growth Horm IGF Res; 2007 Feb; 17(1):33-40. PubMed ID: 17126585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of humoral markers of inflammation and dehydroepiandrosterone sulfate or cortisol serum levels in patients with chronic inflammatory bowel disease.
    Straub RH; Vogl D; Gross V; Lang B; Schölmerich J; Andus T
    Am J Gastroenterol; 1998 Nov; 93(11):2197-202. PubMed ID: 9820396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Responsiveness of IGF-I and IGFBP-3 to therapeutic intervention in children and adolescents with Crohn's disease.
    Beattie RM; Camacho-Hübner C; Wacharasindhu S; Cotterill AM; Walker-Smith JA; Savage MO
    Clin Endocrinol (Oxf); 1998 Oct; 49(4):483-9. PubMed ID: 9876346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased circulating circular RNA_103516 is a novel biomarker for inflammatory bowel disease in adult patients.
    Ye YL; Yin J; Hu T; Zhang LP; Wu LY; Pang Z
    World J Gastroenterol; 2019 Nov; 25(41):6273-6288. PubMed ID: 31749597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum levels of C1q/TNF-related protein-3 in inflammatory bowel disease patients and its inverse association with inflammatory cytokines and insulin resistance.
    Mohamadinarab M; Ahmadi R; Gholamrezayi A; Rahvar F; Naghdalipour M; Setayesh L; Moradi N; Fadaei R; Chamani E; Tavakoli T; Esteghamati A
    IUBMB Life; 2020 Aug; 72(8):1698-1704. PubMed ID: 32311832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum ghrelin levels in inflammatory bowel disease with relation to disease activity and nutritional status.
    Ates Y; Degertekin B; Erdil A; Yaman H; Dagalp K
    Dig Dis Sci; 2008 Aug; 53(8):2215-21. PubMed ID: 18080768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes and relationships of IGFS and IGFBPS and cytokines in coeliac disease at diagnosis and on gluten-free diet.
    Street ME; Volta C; Ziveri MA; Zanacca C; Banchini G; Viani I; Rossi M; Virdis R; Bernasconi S
    Clin Endocrinol (Oxf); 2008 Jan; 68(1):22-8. PubMed ID: 17681027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imbalance between interleukin-1 agonists and antagonists: relationship to severity of inflammatory bowel disease.
    Ludwiczek O; Vannier E; Borggraefe I; Kaser A; Siegmund B; Dinarello CA; Tilg H
    Clin Exp Immunol; 2004 Nov; 138(2):323-9. PubMed ID: 15498044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced formation of advanced oxidation protein products in IBD.
    Krzystek-Korpacka M; Neubauer K; Berdowska I; Boehm D; Zielinski B; Petryszyn P; Terlecki G; Paradowski L; Gamian A
    Inflamm Bowel Dis; 2008 Jun; 14(6):794-802. PubMed ID: 18213700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum Interleukin-33 level in Saudi children with inflammatory bowel disease.
    Saadah OI; Al-Harthi SE; Al-Mughales JA; Bin-Taleb YY; Baeshen RS
    Int J Clin Exp Pathol; 2015; 8(12):16000-6. PubMed ID: 26884875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-6 (IL-6) and IGF-IGFBP system in children and adolescents with type 1 diabetes mellitus.
    Wedrychowicz A; Dziatkowiak H; Sztefko K; Wedrychowicz A
    Exp Clin Endocrinol Diabetes; 2004 Sep; 112(8):435-9. PubMed ID: 15372363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum inter-alpha-trypsin inhibitor heavy chain 4 in patients with inflammatory bowel disease: correlation with disease risk, inflammation, activity, and its variation after treatment.
    Wen N; Zhao N; Xu H; Zhao Y; Ma J
    Ir J Med Sci; 2022 Oct; 191(5):2105-2111. PubMed ID: 34843071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble interleukin-2 receptor, interleukin-6 and interleukin-1 beta in patients with Crohn's disease and ulcerative colitis: preoperative levels and postoperative changes of serum concentrations.
    Schürmann G; Betzler M; Post S; Herfarth C; Meuer S
    Digestion; 1992; 51(1):51-9. PubMed ID: 1639222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the serum levels of Meteorin-like in patients with inflammatory bowel disease and its association with inflammatory cytokines.
    Gholamrezayi A; Mohamadinarab M; Rahbarinejad P; Fallah S; Barez SR; Setayesh L; Moradi N; Fadaei R; Chamani E; Tavakoli T
    Lipids Health Dis; 2020 Oct; 19(1):230. PubMed ID: 33126870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The insulin-like growth factor axis in children with inflammatory bowel disease.
    Corkins MR; Gohil AD; Fitzgerald JF
    J Pediatr Gastroenterol Nutr; 2003 Feb; 36(2):228-34. PubMed ID: 12548059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.